These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29660526)

  • 1. Duodenal Scalloping Indicate Waldenström Macroglobulinemia.
    Francis FF; Kulich S; Hashash JG
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):A17-A18. PubMed ID: 29660526
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmablastic lymphoma transformation in a patient with Waldenström macroglobulinemia treated with ibrutinib.
    Castillo JJ; LaMacchia J; Flynn CA; Sarosiek S; Pozdnyakova O; Treon SP
    Br J Haematol; 2021 Nov; 195(3):466-468. PubMed ID: 34355802
    [No Abstract]   [Full Text] [Related]  

  • 3. Waldenström's macroglobulinemia revealed by atypical blood lymphoid cells.
    Andrieu V; Launay O; Grange MJ
    Haematologica; 1999 Sep; 84(9):858. PubMed ID: 10477462
    [No Abstract]   [Full Text] [Related]  

  • 4. Waldenström macroglobulinaemia and intestinal lymphangiectasia.
    Cooke RE; Kalnins RM; Ho WK
    Br J Haematol; 2014 Nov; 167(3):292. PubMed ID: 25039993
    [No Abstract]   [Full Text] [Related]  

  • 5. Waldenström macroglobulinemia with pseudo-Gaucher cells.
    Ash Image Bank
    Blood; 2010 Nov; 116(18):3388. PubMed ID: 21089228
    [No Abstract]   [Full Text] [Related]  

  • 6. Case records of the Massachusetts General Hospital. Case 40-2006. A 64-year-old man with anemia and a low level of HDL cholesterol.
    Murali MR; Kratz A; Finberg KE
    N Engl J Med; 2006 Dec; 355(26):2772-9. PubMed ID: 17192544
    [No Abstract]   [Full Text] [Related]  

  • 7. Spurious fibrinogen levels secondary to pyroglobulinemia in Waldenström's macroglobulinemia.
    Cagnoni PJ; Lenzi R; Wisch N; Seremetis S; Rand JH
    Am J Hematol; 1995 Feb; 48(2):126-7. PubMed ID: 7847327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete remission of Waldenström's associated generalized crystal-storing histiocytosis of IgM lambda subtype with bortezomib-based combination chemotherapy.
    Baird SM; Kenealy MK; Hoy R
    Leuk Lymphoma; 2015; 56(11):3233-5. PubMed ID: 25837422
    [No Abstract]   [Full Text] [Related]  

  • 9. Simultaneous occurrence of clinical manifestations of myeloma and Waldenström's macroglobulinemia with monoclonal IgG Lambda and IgM Kappa in a single patient.
    Fine JM; Gorin NC; Gendre JP; Petitpierre JC; Labro-Bryskier MT; Lambin P
    Acta Med Scand; 1981; 209(3):229-34. PubMed ID: 6784449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG myeloma and Waldenström macroglobulinemia. Coexistence and clinical manifestations in one patient.
    McNutt DR; Fudenberg HH
    Arch Intern Med; 1973 May; 131(5):731-6. PubMed ID: 4633790
    [No Abstract]   [Full Text] [Related]  

  • 11. Lymphoplasmacytic lymphoma with Waldenstrom's macroglobulinemia as a reason for peripheral arterial perfusion disorders.
    Zgouras D; Engels K; Lindhoff-Last E
    Vasa; 2009 May; 38(2):193-6. PubMed ID: 19588311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric MALT lymphoma presenting as Waldenström's macroglobulinemia without bone marrow involvement.
    Salle V; Smail A; Joly JP; Capiod JC; Gontier MF; Duhaut P; Ducroix JP
    Clin Lymphoma Myeloma; 2007 Jul; 7(7):470-1. PubMed ID: 17875236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Waldenström macroglobulinemia.
    Gertz MA
    Hematology; 2012 Apr; 17 Suppl 1():S112-6. PubMed ID: 22507796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macroglobulinemia with abdominal symptoms caused by intestinal extracellular macroglobulin.
    Mattila J; Alavaikko M; Järventie G; Lehtinen M; Pitkänen R
    Virchows Arch A Pathol Anat Histol; 1980; 389(2):241-51. PubMed ID: 6779414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waldenstrom macroglobulinemia presenting with pancreatic mass: a case report and review of literature.
    Nayak HK; Kar P; Bagchi A; Kapoor N; Kapahtia S; Sonika U; Kumar N; Kumar S
    JOP; 2013 Jan; 14(1):92-5. PubMed ID: 23306344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary macroglobulinemia associated with bone destruction].
    Kanoh T; Nishizaka Y; Takamatsu T; Ohno T; Uchino H
    Nihon Naika Gakkai Zasshi; 1986 Jul; 75(7):936-40. PubMed ID: 3097216
    [No Abstract]   [Full Text] [Related]  

  • 17. Coexisting cutaneous macroglobulinosis and scleredema of Buschke in a patient with a Waldenström Macroglobulinemia.
    Roupie AL; Battistella M; Talbot A; Jachiet M; Bouaziz JD; Vignon-Pennamen MD; Royer B; Fermand JP; Arnulf B; Harel S
    J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):e104-e106. PubMed ID: 30267590
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathology of macroglobulinemia--a review of Japanese cases.
    Yamaguchi K
    Acta Pathol Jpn; 1973 Nov; 23(4):917-52. PubMed ID: 4206123
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of POEMS syndrome associated with reactive amyloidosis and Waldenström's macroglobulinaemia.
    Kihara Y; Hori H; Murakami H; Hatakeyama Y; Yoshikawa I; Hamada T; Otsuki M
    J Intern Med; 2002 Sep; 252(3):255-8. PubMed ID: 12270006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-proteinuric renal al amyloidosis in waldenström's macroglobulinemia.
    Lesourd A; Francois A; Etienne I; Guerrot D
    Nephrology (Carlton); 2019 Apr; 24(4):490-491. PubMed ID: 30919534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.